Cancer treatment places physical, emotional, and financial burdens on patients and their families. Oral cancer therapy provides some benefits to patients; however, the cost associated with oral therapy is overwhelming. Patient outcomes for oral therapy depend on effective patient education about adherence to the prescribed regimen, management of treatment-related symptoms, and ongoing follow-up. This course provides nurses, pharmacists, and providers with an evidence-based overview of the barriers to effective medication adherence and strategies for managing patients receiving oral chemotherapy. By providing high-quality and frequent education, clinicians help patients receive the greatest benefits from their therapy.
The goal of this course is to provide nurses, pharmacists, and physicians with an overview of interventions to improve patients' adherence to oral chemotherapy.
Cancer treatment places physical, emotional, and financial burdens on patients and their families. Oral cancer therapy provides some benefits to patients; however, the cost associated with oral therapy is overwhelming. Patient outcomes for oral therapy depend on effective patient education about adherence to the prescribed regimen, management of treatment-related symptoms, and ongoing follow-up. This course provides nurses, pharmacists, and providers with an evidence-based overview of the barriers to effective medication adherence and strategies for managing patients receiving oral chemotherapy. By providing high-quality and frequent education, clinicians help patients receive the greatest benefits from their therapy. The goal of this course is to provide nurses, pharmacists, and physicians with an overview of interventions to improve patients' adherence to oral chemotherapy.
District of Columbia Board of Nursing Approved Continuing Education program (CEBroker Provider #50-290).
Florida Board of Nursing (CEBroker Provider #50-290)
In support of improving patient care, Relias LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Georgia Board of Nursing (CEBroker Provider #50-290)
In support of improving patient care, Relias LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
South Carolina Board of Nursing (CEBroker Provider #50-290)
Florida Board of Medicine (CEBroker Provider #50-290)
Physicians will receive 1.00 AMA PRA category 1 Credits™.
West Virginia Board of Registered Nursing (CEBroker Provider #50-290)
In support of improving patient care, Relias LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
New Mexico Board of Nursing (CEBroker Provider #50-290)
Arkansas State Board Of Nursing Approved Continuing Education program (CEBroker Provider #50-290).
State Medical Board of Ohio (CEBroker Provider #: 50-290)
Louisiana State Board of Medical Examiners (CEBroker Provider #: 50-290)
Mississippi State Board of Medical Licensure (CEBroker Provider #: 50-290)
Florida Board of Pharmacy (CEBroker Provider #50-290)
Kentucky Board of Nursing (CEBroker Provider #50-290)
Nurses will receive 1.00 contact hours for participating in this course.
Mississippi Board of Nursing (CEBroker Provider #50-290)
North Dakota Board of Nursing (CEBroker Provider #50-290)
Physicians will receive 1.00 AMA PRA category 1 Credits™.
South Carolina Board of Medical Examiners (CEBroker Provider #50-290)
Tennessee Board of Medical Examiners (CEBroker Provider #50-290)>
Physicians will receive 1.00 AMA PRA category 1 Credits™
Michigan Board of Pharmacy (CEBroker Provider #50-290)
Outline:
Section 2: Cancer Home Therapy
Advantages of Oral Anti-Cancer Treatment
Challenges with Medication Adherence
Health Systems Related Factors
Section 3: Adherence Education
Interventions that Promote Adherence
Assessment of Food and Drug Interactions
Section 4: Promoting Adherence
Reviewer: Johnny J. Bethea, II, RPhMonica Caicedo Orellana, MS, RN, OCN, is an SME writer for Relias with over 16 years of acute care experience in nursing. She is licensed as a professional registered nurse in the State of New York. She obtained her OCN certification in 2008. She has served in several leadership roles in the acute care setting, within the Medical Surgical Division, mentoring nurses in renal and oncology specialties, and the role of nurse educator. She has been involved in various institutional committees and quality improvement projects. Monica earned a master’s degree in nursing education from New York University Rory Meyers College of Nursing.
Disclosure: Monica Caicedo Orellana, MS, RN, OCN, CNE has no Relevant Financial or Non-Financial Relationship with ineligible companies to disclose.
Johnny received a B.S. Pharmacy degree from the College of Pharmacy at the Medical University of South Carolina. He has earned certificates in Medication Therapy Management, Injectable Medications, and Asthma Therapy Management. At Relias, Johnny serves as a Partner in Behavioral Health Solutions, where duties include serving on Clinical Analytics and Applications Team, developing algorithms to improve clinical outcomes, engineering clinical consultant, SME, writer, and editor. In addition, he has served on the Executive Board of Directors for CMHCs and other medical organizations, pharmacy manager, APPE Preceptor, and college of pharmacy dean’s advisory council. Disclosure: Johnny J. Bethea, II, RPh discloses the following potential conflict of interests/commercial interests: Relevant Financial Relationship with Relias LLC as a Salaried Employee All of the relationships listed for this individual have been mitigated.Relevant Non-Financial Relationship with No Entities Exists as a Contributor All of the relationships listed for this individual have been mitigated.
Access to over 1,450 courses! Access to 1,450+ courses for one low price.